s65487
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2019 (NCT03755154)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Apoptosis regulator Bcl-2INHIBITOR
BCL2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04702425 | Phase 1 | Jun 23, 2021 | Novartis |
| NCT04742101 | Phase 1/Phase 2 (Phase 2) | Mar 10, 2021 | Servier |
| NCT03755154 | Phase 1 | Jul 31, 2019 | Servier |
Showing 3 of 3 trials
Page 1 / 1